Cochrane Canada is a Canadian nonprofit organization based in Hamilton, Ontario. It is part of the Cochrane network.
During the COVID-19 pandemic, Cochrane Canada participated in the Evidence Synthesis Network (ESN), a partner initiative of the Ontario COVID-19 Science Advisory Table (OST).[1][2]
Cochrane Canada is affiliated with 26 partner organizations, each with a designated representative who liaises with CC's Knowledge Broker.[3]
Cochrane Canada has received funding and support from:[4]
Name | Position | Notes |
---|---|---|
Holger Schüenemann | Director (former)[5] | McMaster University, University of Freiburg, University of Buffalo, GRADE Working Group, Guidelines International Network (G-I-N), COVID-19 Evidence Network to Support Decision-making (COVID-END) |
Evidence & Knowledge for COVID-19 Response. Evidence Synthesis Network. Retrieved May 9, 2022, from http://archive.today/2021.03.14-063900/https://esnetwork.ca/ ↩︎
Our Partners. Ontario COVID-19 Science Advisory Table. Retrieved May 9, 2022, from https://web.archive.org/web/20220509143427/https://covid19-sciencetable.ca/our-partners/ ↩︎
Partners. Cochrane Canada. Retrieved April 22, 2021, from http://archive.today/2021.04.22-051708/https://canada.cochrane.org/partners-0 ↩︎
Funding and Support. Cochrane Canada. Retrieved June 11, 2022, from http://archive.today/2022.06.11-182810/https://canada.cochrane.org/funding-and-support ↩︎
Bero, L., & Farquhar, C. (2016, September 7). Cochrane Steering Group announces change in membership. Cochrane Community. http://archive.today/2022.06.10-073940/https://community.cochrane.org/news/cochrane-steering-group-announces-change-membership ↩︎